img

Global Physostigmine Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Physostigmine Market Research Report 2024

Physostigmine is a parasympathomimetic, specifically, a reversible cholinesterase inhibitor which effectively increases the concentration of acetylcholine at the sites of cholinergic transmission. Physostigmine is used to treat glaucoma. Because it crosses the blood-brain barrier, it is also used to treat the central nervous system effects of atropine overdose and other anticholinergic drug overdoses. Physostigmine can reverse both central and peripheral anticholinergia
According to Mr Accuracy reports’s new survey, global Physostigmine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Physostigmine market research.
Key manufacturers engaged in the Physostigmine industry include Alcon, Akorn, IFET, Merck and Hangzhou APIChem, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Physostigmine were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Physostigmine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Physostigmine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Alcon
Akorn
IFET
Merck
Hangzhou APIChem
Segment by Type
Intravenous
Intramuscular
Ophthalmic

Segment by Application


Hospital
Drug Store

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Physostigmine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Physostigmine Market Overview
1.1 Product Overview and Scope of Physostigmine
1.2 Physostigmine Segment by Type
1.2.1 Global Physostigmine Market Value Comparison by Type (2024-2034)
1.2.2 Intravenous
1.2.3 Intramuscular
1.2.4 Ophthalmic
1.3 Physostigmine Segment by Application
1.3.1 Global Physostigmine Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Physostigmine Market Size Estimates and Forecasts
1.4.1 Global Physostigmine Revenue 2018-2034
1.4.2 Global Physostigmine Sales 2018-2034
1.4.3 Global Physostigmine Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Physostigmine Market Competition by Manufacturers
2.1 Global Physostigmine Sales Market Share by Manufacturers (2018-2024)
2.2 Global Physostigmine Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Physostigmine Average Price by Manufacturers (2018-2024)
2.4 Global Physostigmine Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Physostigmine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Physostigmine, Product Type & Application
2.7 Physostigmine Market Competitive Situation and Trends
2.7.1 Physostigmine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Physostigmine Players Market Share by Revenue
2.7.3 Global Physostigmine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Physostigmine Retrospective Market Scenario by Region
3.1 Global Physostigmine Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Physostigmine Global Physostigmine Sales by Region: 2018-2034
3.2.1 Global Physostigmine Sales by Region: 2018-2024
3.2.2 Global Physostigmine Sales by Region: 2024-2034
3.3 Global Physostigmine Global Physostigmine Revenue by Region: 2018-2034
3.3.1 Global Physostigmine Revenue by Region: 2018-2024
3.3.2 Global Physostigmine Revenue by Region: 2024-2034
3.4 North America Physostigmine Market Facts & Figures by Country
3.4.1 North America Physostigmine Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Physostigmine Sales by Country (2018-2034)
3.4.3 North America Physostigmine Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Physostigmine Market Facts & Figures by Country
3.5.1 Europe Physostigmine Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Physostigmine Sales by Country (2018-2034)
3.5.3 Europe Physostigmine Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Physostigmine Market Facts & Figures by Country
3.6.1 Asia Pacific Physostigmine Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Physostigmine Sales by Country (2018-2034)
3.6.3 Asia Pacific Physostigmine Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Physostigmine Market Facts & Figures by Country
3.7.1 Latin America Physostigmine Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Physostigmine Sales by Country (2018-2034)
3.7.3 Latin America Physostigmine Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Physostigmine Market Facts & Figures by Country
3.8.1 Middle East and Africa Physostigmine Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Physostigmine Sales by Country (2018-2034)
3.8.3 Middle East and Africa Physostigmine Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Physostigmine Sales by Type (2018-2034)
4.1.1 Global Physostigmine Sales by Type (2018-2024)
4.1.2 Global Physostigmine Sales by Type (2024-2034)
4.1.3 Global Physostigmine Sales Market Share by Type (2018-2034)
4.2 Global Physostigmine Revenue by Type (2018-2034)
4.2.1 Global Physostigmine Revenue by Type (2018-2024)
4.2.2 Global Physostigmine Revenue by Type (2024-2034)
4.2.3 Global Physostigmine Revenue Market Share by Type (2018-2034)
4.3 Global Physostigmine Price by Type (2018-2034)
5 Segment by Application
5.1 Global Physostigmine Sales by Application (2018-2034)
5.1.1 Global Physostigmine Sales by Application (2018-2024)
5.1.2 Global Physostigmine Sales by Application (2024-2034)
5.1.3 Global Physostigmine Sales Market Share by Application (2018-2034)
5.2 Global Physostigmine Revenue by Application (2018-2034)
5.2.1 Global Physostigmine Revenue by Application (2018-2024)
5.2.2 Global Physostigmine Revenue by Application (2024-2034)
5.2.3 Global Physostigmine Revenue Market Share by Application (2018-2034)
5.3 Global Physostigmine Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Alcon
6.1.1 Alcon Corporation Information
6.1.2 Alcon Description and Business Overview
6.1.3 Alcon Physostigmine Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Alcon Physostigmine Product Portfolio
6.1.5 Alcon Recent Developments/Updates
6.2 Akorn
6.2.1 Akorn Corporation Information
6.2.2 Akorn Description and Business Overview
6.2.3 Akorn Physostigmine Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Akorn Physostigmine Product Portfolio
6.2.5 Akorn Recent Developments/Updates
6.3 IFET
6.3.1 IFET Corporation Information
6.3.2 IFET Description and Business Overview
6.3.3 IFET Physostigmine Sales, Revenue and Gross Margin (2018-2024)
6.3.4 IFET Physostigmine Product Portfolio
6.3.5 IFET Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Physostigmine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Merck Physostigmine Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Hangzhou APIChem
6.5.1 Hangzhou APIChem Corporation Information
6.5.2 Hangzhou APIChem Description and Business Overview
6.5.3 Hangzhou APIChem Physostigmine Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Hangzhou APIChem Physostigmine Product Portfolio
6.5.5 Hangzhou APIChem Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Physostigmine Industry Chain Analysis
7.2 Physostigmine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Physostigmine Production Mode & Process
7.4 Physostigmine Sales and Marketing
7.4.1 Physostigmine Sales Channels
7.4.2 Physostigmine Distributors
7.5 Physostigmine Customers
8 Physostigmine Market Dynamics
8.1 Physostigmine Industry Trends
8.2 Physostigmine Market Drivers
8.3 Physostigmine Market Challenges
8.4 Physostigmine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Physostigmine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Physostigmine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Physostigmine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Physostigmine Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Physostigmine Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Physostigmine Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Physostigmine Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Physostigmine Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Physostigmine, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Physostigmine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Physostigmine, Product Type & Application
Table 12. Global Key Manufacturers of Physostigmine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Physostigmine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Physostigmine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Physostigmine Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Physostigmine Sales by Region (2018-2024) & (K Units)
Table 18. Global Physostigmine Sales Market Share by Region (2018-2024)
Table 19. Global Physostigmine Sales by Region (2024-2034) & (K Units)
Table 20. Global Physostigmine Sales Market Share by Region (2024-2034)
Table 21. Global Physostigmine Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Physostigmine Revenue Market Share by Region (2018-2024)
Table 23. Global Physostigmine Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Physostigmine Revenue Market Share by Region (2024-2034)
Table 25. North America Physostigmine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Physostigmine Sales by Country (2018-2024) & (K Units)
Table 27. North America Physostigmine Sales by Country (2024-2034) & (K Units)
Table 28. North America Physostigmine Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Physostigmine Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Physostigmine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Physostigmine Sales by Country (2018-2024) & (K Units)
Table 32. Europe Physostigmine Sales by Country (2024-2034) & (K Units)
Table 33. Europe Physostigmine Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Physostigmine Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Physostigmine Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Physostigmine Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Physostigmine Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Physostigmine Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Physostigmine Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Physostigmine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Physostigmine Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Physostigmine Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Physostigmine Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Physostigmine Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Physostigmine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Physostigmine Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Physostigmine Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Physostigmine Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Physostigmine Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Physostigmine Sales (K Units) by Type (2018-2024)
Table 51. Global Physostigmine Sales (K Units) by Type (2024-2034)
Table 52. Global Physostigmine Sales Market Share by Type (2018-2024)
Table 53. Global Physostigmine Sales Market Share by Type (2024-2034)
Table 54. Global Physostigmine Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Physostigmine Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Physostigmine Revenue Market Share by Type (2018-2024)
Table 57. Global Physostigmine Revenue Market Share by Type (2024-2034)
Table 58. Global Physostigmine Price (US$/Unit) by Type (2018-2024)
Table 59. Global Physostigmine Price (US$/Unit) by Type (2024-2034)
Table 60. Global Physostigmine Sales (K Units) by Application (2018-2024)
Table 61. Global Physostigmine Sales (K Units) by Application (2024-2034)
Table 62. Global Physostigmine Sales Market Share by Application (2018-2024)
Table 63. Global Physostigmine Sales Market Share by Application (2024-2034)
Table 64. Global Physostigmine Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Physostigmine Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Physostigmine Revenue Market Share by Application (2018-2024)
Table 67. Global Physostigmine Revenue Market Share by Application (2024-2034)
Table 68. Global Physostigmine Price (US$/Unit) by Application (2018-2024)
Table 69. Global Physostigmine Price (US$/Unit) by Application (2024-2034)
Table 70. Alcon Corporation Information
Table 71. Alcon Description and Business Overview
Table 72. Alcon Physostigmine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Alcon Physostigmine Product
Table 74. Alcon Recent Developments/Updates
Table 75. Akorn Corporation Information
Table 76. Akorn Description and Business Overview
Table 77. Akorn Physostigmine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Akorn Physostigmine Product
Table 79. Akorn Recent Developments/Updates
Table 80. IFET Corporation Information
Table 81. IFET Description and Business Overview
Table 82. IFET Physostigmine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. IFET Physostigmine Product
Table 84. IFET Recent Developments/Updates
Table 85. Merck Corporation Information
Table 86. Merck Description and Business Overview
Table 87. Merck Physostigmine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Merck Physostigmine Product
Table 89. Merck Recent Developments/Updates
Table 90. Hangzhou APIChem Corporation Information
Table 91. Hangzhou APIChem Description and Business Overview
Table 92. Hangzhou APIChem Physostigmine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Hangzhou APIChem Physostigmine Product
Table 94. Hangzhou APIChem Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Physostigmine Distributors List
Table 98. Physostigmine Customers List
Table 99. Physostigmine Market Trends
Table 100. Physostigmine Market Drivers
Table 101. Physostigmine Market Challenges
Table 102. Physostigmine Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Physostigmine
Figure 2. Global Physostigmine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Physostigmine Market Share by Type in 2022 & 2034
Figure 4. Intravenous Product Picture
Figure 5. Intramuscular Product Picture
Figure 6. Ophthalmic Product Picture
Figure 7. Global Physostigmine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Physostigmine Market Share by Application in 2022 & 2034
Figure 9. Hospital
Figure 10. Drug Store
Figure 11. Global Physostigmine Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 12. Global Physostigmine Market Size (2018-2034) & (US$ Million)
Figure 13. Global Physostigmine Sales (2018-2034) & (K Units)
Figure 14. Global Physostigmine Average Price (US$/Unit) & (2018-2034)
Figure 15. Physostigmine Report Years Considered
Figure 16. Physostigmine Sales Share by Manufacturers in 2022
Figure 17. Global Physostigmine Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Physostigmine Players: Market Share by Revenue in 2022
Figure 19. Physostigmine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Physostigmine Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 21. North America Physostigmine Sales Market Share by Country (2018-2034)
Figure 22. North America Physostigmine Revenue Market Share by Country (2018-2034)
Figure 23. United States Physostigmine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Canada Physostigmine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Europe Physostigmine Sales Market Share by Country (2018-2034)
Figure 26. Europe Physostigmine Revenue Market Share by Country (2018-2034)
Figure 27. Germany Physostigmine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. France Physostigmine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. U.K. Physostigmine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Italy Physostigmine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Russia Physostigmine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Asia Pacific Physostigmine Sales Market Share by Region (2018-2034)
Figure 33. Asia Pacific Physostigmine Revenue Market Share by Region (2018-2034)
Figure 34. China Physostigmine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Japan Physostigmine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. South Korea Physostigmine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. India Physostigmine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Australia Physostigmine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. China Taiwan Physostigmine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Indonesia Physostigmine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Thailand Physostigmine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Malaysia Physostigmine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Latin America Physostigmine Sales Market Share by Country (2018-2034)
Figure 44. Latin America Physostigmine Revenue Market Share by Country (2018-2034)
Figure 45. Mexico Physostigmine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Brazil Physostigmine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Argentina Physostigmine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Middle East & Africa Physostigmine Sales Market Share by Country (2018-2034)
Figure 49. Middle East & Africa Physostigmine Revenue Market Share by Country (2018-2034)
Figure 50. Turkey Physostigmine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Saudi Arabia Physostigmine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. UAE Physostigmine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Global Sales Market Share of Physostigmine by Type (2018-2034)
Figure 54. Global Revenue Market Share of Physostigmine by Type (2018-2034)
Figure 55. Global Physostigmine Price (US$/Unit) by Type (2018-2034)
Figure 56. Global Sales Market Share of Physostigmine by Application (2018-2034)
Figure 57. Global Revenue Market Share of Physostigmine by Application (2018-2034)
Figure 58. Global Physostigmine Price (US$/Unit) by Application (2018-2034)
Figure 59. Physostigmine Value Chain
Figure 60. Physostigmine Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed